Answers are grounded in this paper and cite their sources.
Pharmaceutical water systems constitute a critical utility within the pharmaceutical manufacturing. Water plays a pivotal role in various stages—including synthesis, formulation, and cleaning—yet simultaneously acting as a potential source of microbial contamination. To ensure the quality and safety of pharmaceutical products, global regulatory authorities and international organizations have established rigorous standards governing microbial control in pharmaceutical water. Within this regulatory framework, systematic approaches and policies for microbial testing and oversight have been developed worldwide. However, due to the limitations of testing methods and the complex nature of pharmaceutical water systems, several challenges regarding microbial detection remain unresolved. This review provides a comprehensive overview covering the classification of pharmaceutical water, the origins and risks of microbial contamination (including biofilm formation and opportunistic pathogens), and current microbial control strategies (such as thermal sterilization, ozonation, and reverse osmosis), along with remediation approaches (including disinfectants and preservatives). In the realm of microbial detection, it also systematically summarizes and discusses the advantages and limitations of both traditional and novel detection methods. Although traditional culture-based methods remain the regulatory benchmark, their inherent limitations—such as protracted procedures and restricted sensitivity—have spurred the advancement of rapid microbiological methods (RMMs), including PCR, ATP bioluminescence, and biosensors. These new methods are gaining regulatory acceptance, with increasing advocacy for their use—subject to thorough validation—to enable real-time monitoring and process control. Nevertheless, practical application of these novel methods in the pharmaceutical water industry faces limitations and requires further implementation. Looking ahead, microbial detection in pharmaceutical water is poised to evolve toward real-time, continuous, and intelligent monitoring; concurrently, standardization and international harmonization will be essential for the broad implementation of these emerging technologies.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: